计算溶液所需的质量、体积或浓度。
| 活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
|---|
,适用于对基线干扰要求严格的色谱和分析工作流程。
-80℃储存。特低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
PF-06256142 is a potent, selective, CNS-penetrant and orally active agonist of the D1 receptor , with an EC 50 and K i of 33 nM and 12 nM, respectively. PF-06256142 has the potential for the research of schizophrenia and Parkinson's disease
In Vitro
PF-06256142 exhibits IC 50 values of <5 μM as an antagonist at the following 4 targets: M 1 (4.9 μM); CB1 (2.1 μM); H 1 (4.6 μM); Nav 1.5 (1.1 μM). PF-06256142 has an IC 50 of approximately 12 μM for hERG. PF-06256142 shows a K i of 4.8 nM for D5 exquisitely selective than D2 (K i >10 μM). MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
PF-06256142 exhibits high oral bioavailability (rat 85%) following oral administration (rat 5 mg/kg) . PF-06256142 exhibits terminal elimination half-life (rat 2.3 h) following intravenous administration (rat 5.0 mg/kg) . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Rat Dosage: 5.0 mg/kg for i.v.; 5 mg/kg for oral (Pharmacokinetic Analysis) Administration: Intravenous injection and oral administration Result: Oral bioavailability (85%), T 1/2 (2.3 h).
IC50& Target:Human D 1 Receptor 33 nM (EC 50 )